OTC · Drug Manufacturers - Specialty & Generic

Creso Pharma Limited (COPHF) Stock

$0.12 +0.00% OTC: COPHF Healthcare

Creso Pharma Limited is a global pharmaceutical company focused on the development, registration, and commercialization of advanced cannabis and hemp-based solutions. These therapeutic products and nutraceuticals are designed for both human and animal health applications, with market presence spanning Europe, the Middle East, North America, and the Asia Pacific region.

Valuation

MetricValue
Price$0.12
Market Cap$131.72M
P/E Ratio-0.40
P/B Ratio0.59
P/S Ratio2.66
EPS (TTM)$0.00
52-Week High$9.47
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-130.99%
ROA-86.31%
ROCE-87.77%
Gross Margin3.30%
Operating Margin-225.19%
Net Margin-377.28%
Debt/Equity0.30
Current Ratio0.76

Annual Financials (USD)

Metric20192020202120222023
Revenue$4.0M$2.0M$6.0M$9.0M$19.0M
Operating Profit$-10.0M$-17.0M$-28.0M$-20.0M$-17.0M
Net Profit$-17.0M$-38.0M$-32.0M$-33.0M$-52.0M
EPS$-0.12$-0.10$-0.03$-0.02$0.00
Op Margin-281.5%-688.0%-455.5%-225.2%-88.2%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$23.0M$19.0M$29.0M$38.0M$19.0M
Total Liabilities$5.0M$5.0M$2.0M$16.0M$23.0M
Cash$3.0M$6.0M$7.0M$1.0M$1.0M
Borrowings$3.0M$3.0M$0$7.0M$10.0M

Latest News

TowneBank Q2 Earnings, Revenue Rise MT Newswires · Jul 23, 2026 Renault says sales stalled in first half AFP · Jul 23, 2026 Should You Buy Amazon and Meta Platforms Stocks Before July 29? Motley Fool · Jul 23, 2026 argenx Q2 Profit, Total Operating Income Rise MT Newswires · Jul 23, 2026 STMicroelectronics Q2 Non-GAAP Earnings, Revenue Rise MT Newswires · Jul 23, 2026

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-10.0M$-10.0M$-22.0M$-31.0M$0
Investing Cash Flow$-7.0M$-1.0M$-2.0M$-3.0M$0
Financing Cash Flow$10.0M$12.0M$23.0M$-1.0M$4.0M
Net Cash Flow$-4.0M$3.0M$1.0M$-6.0M$-1.0M
Free Cash Flow$-14.0M$-10.0M$-23.0M$-31.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.94
FCF Yield-134.95%
Quick Ratio0.39
Interest Coverage-28.28
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPGVAscentage Pharma Group International $17.38 +0.75% -9.87 $127.31M 0.00%
AMEUFAnteris Technologies Ltd $5.70 -35.81% -3.37 $120.50M 0.00%
AMGXFAnGes, Inc. $0.36 +0.00% -3.40 $142.50M 0.00%
CMXCCell MedX Corp. $0.43 — -11.01 $126.33M 0.00%
CNVCFBioHarvest Sciences Inc. $6.30 — -7.06 $109.16M 0.00%

About Creso Pharma Limited

Creso Pharma Limited is a global pharmaceutical company focused on the development, registration, and commercialization of advanced cannabis and hemp-based solutions. These therapeutic products and nutraceuticals are designed for both human and animal health applications, with market presence spanning Europe, the Middle East, North America, and the Asia Pacific region. Beyond innovative product creation, the company also manages the cultivation, processing, and distribution of cannabis products, extending its reach to the retail sector. Its diverse portfolio includes specialized offerings such as anibidiol, a complementary nutritional supplement for companion animals. For human wellness, they provide cannaQIX, a nutraceutical blend of hemp oil extract, vitamins, and zinc, formulated to alleviate stress and bolster psychological and neurological functions. The company also manufactures topical and dermatological products, including cannaDOL, a CBD-infused gel combining cooling and warming essential oils. Established in 2015, Creso Pharma Limited maintains its headquarters in Nedlands, Australia.

Creso Pharma Limited is headquartered in AU.

Creso Pharma Limited (COPHF) stock trades at $0.12 with a market capitalization of $131.72M. The stock is valued at a price-to-earnings (P/E) ratio of -0.40, price-to-book of 0.59, price-to-sales of 2.66. Over the past 52 weeks the stock has ranged between $0.00 and $9.47, and currently trades 98.7% below its 52-week high.

On profitability, Creso Pharma Limited generates a return on equity (ROE) of -130.99%, return on capital employed of -87.77%, an operating margin of -225.19%, a net profit margin of -377.28%.

Official website: www.cresopharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides